hly4ddoc | Knowledge4COVID-19

Property	Value
?:abstract	COVID‐19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/hly4ddoc_hasAnnotation_C0013227>
?:creator	<https://research.tib.eu/covid-19/entity/Dass%2C_Bhagwan%3B_Beck%2C_Andrew%3B_Holmes%2C_Cody%3B_Morton%2C_Glenville>
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/ccr3.3540>
?:doi	10.1002/ccr3.3540
?:journal	Clin_Case_Rep
?:license	cc-by
?:pdf_json_files	document_parses/pdf_json/a78458cd72d13cf4dec831e1910ee9521ef6ebc8.json
?:pmc_json_files	document_parses/pmc_json/PMC7753533.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7753533>
?:pmid	<https://research.tib.eu/covid-19/entity/33362928.0>
?:pmid	33362928.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/hly4ddoc_HAS_C5203670_CAUSES_C0011880>
?:sha_id	<https://research.tib.eu/covid-19/entity/a78458cd72d13cf4dec831e1910ee9521ef6ebc8>
?:source	Medline; PMC
?:title	Euglycemic DKA (euDKA) as a presentation of COVID‐19
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-20

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/hly4ddoc>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/hly4ddoc>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all